Vikas Yadav
21 – 30 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Translational research in drug discovery : Tiny steps before the giant leap
2021) p.347-369(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
WNT5A-induced activation of the protein kinase C substrate MARCKS is required for melanoma cell invasion
(
- Contribution to journal › Article
- 2019
-
Mark
Antimicrobial Peptides & Leucine Zipper Motif: A legitimate affair in quest of best antibiotic drug
2019)(
- Book/Report › Book
-
Mark
Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth
(
- Contribution to journal › Article
- 2016
-
Mark
Lipid rafts in immune signalling: current progress and future perspective
(
- Contribution to journal › Scientific review
- 2015
-
Mark
MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
(
- Contribution to journal › Article
-
Mark
Systematic analysis of mycobacterial acylation reveals first example of acylation-mediated regulation of enzyme activity of a bacterial phosphatase
(
- Contribution to journal › Article
-
Mark
Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation
(
- Contribution to journal › Article
- 2012
-
Mark
Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53
(
- Contribution to journal › Article